Cocrystal Pharma, Inc. (COCP)
$1.10-$0.04 (-3.51%) Today
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). The company has one reportable and operating segment dedicated to the research and development company's novel orally administered antiviral influenza candidate. The company has pipeline products for diseases like : Influenza, Norovirus, Coronavirus, Respiratory Viruses, and Hepatitis C.
https://www.cocrystalpharma.comSEC filings for COCP on EDGAR
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 2 | 85,000 | $80K |
| Grant or award | 1 | 235,000 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
30 Form 4 filings on record, the earliest from Oct 11, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Phillip Md Et Al Frost - Director | Open-market purchase | Common Stock | 10,000 | $0.98 | $10K | |
| Phillip Md Et Al Frost - Director | Open-market purchase | Common Stock | 75,000 | $0.94 | $71K | |
| James Sapirstein - Officer | Grant or award | Stock Options (Right to Buy) | 235,000 | $0.00 | - | |
| Phillip Md Et Al Frost - Director | Open-market purchase | Common Stock | 20,000 | $1.00 | $20K | |
| Phillip Md Et Al Frost - Director | Open-market purchase | Common Stock | 50,000 | $0.95 | $47K | |
| Roger D. Kornberg - Director | Grant or award | Stock Options (Right to Buy) | 24,615 | $0.00 | - | |
| Richard C. Pfenniger Jr. - Director | Grant or award | Stock Options (Right to Buy) | 16,410 | $0.00 | - | |
| Sam Lee - Officer | Grant or award | Stock Options (Right to Buy) | 49,229 | $0.00 | - | |
 Fred Hassan - Director | Grant or award | Stock Options (Right to Buy) | 16,410 | $0.00 | - | |
| James Joseph Martin - Officer | Grant or award | Stock Options (Right to Buy) | 49,229 | $0.00 | - | |
| Phillip Md Et Al Frost - Director | Grant or award | Stock Options (Right to Buy) | 24,615 | $0.00 | - | |
| Anthony J. Japour - Director | Grant or award | Stock Options (Right to Buy) | 16,410 | $0.00 | - | |
| Steven D. Rubin - Director | Grant or award | Stock Options (Right to Buy) | 16,410 | $0.00 | - | |
| Phillip Md Et Al Frost - Director | Open-market purchase | Common Stock | 50,000 | $0.95 | $47K | |
| Phillip Md Et Al Frost - Director | Open-market purchase | Common Stock | 20,000 | $0.97 | $19K | |
| Phillip Md Et Al Frost - Director | Open-market purchase | Common Stock | 25,000 | $0.97 | $24K | |
| Phillip Md Et Al Frost - Director | Open-market purchase | Common Stock | 40,000 | $0.97 | $39K | |
| Phillip Md Et Al Frost - Director | Open-market purchase | Common Stock | 1,500 | $1.00 | $2K | |
| Phillip Md Et Al Frost - Director | Open-market purchase | Common Stock | 2,500 | $0.99 | $2K | |
| Phillip Md Et Al Frost - Director | Open-market purchase | Common Stock | 20,000 | $0.94 | $19K | |
| Phillip Md Et Al Frost - Director | Grant or award | Warrants | 719,426 | $1.39 | $1.00M | |
| Phillip Md Et Al Frost - Director | Grant or award | Common Stock | 359,713 | $1.39 | $500K | |
| Fred Hassan - Director | Grant or award | Common Stock | 359,713 | $1.39 | $500K | |
| Fred Hassan - Director | Grant or award | Warrants | 719,426 | $1.39 | $1.00M | |
| James Joseph Martin - Officer | Grant or award | Common Stock | 3,598 | $1.39 | $5K | |
| James Joseph Martin - Officer | Grant or award | Warrants | 7,196 | $1.39 | $10K | |
| Richard C. Pfenniger Jr. - Director | Grant or award | Common Stock | 20,000 | - | - | |
| Richard C. Pfenniger Jr. - Director | Grant or award | Warrants | 40,000 | $1.39 | $56K | |
| Fred Hassan - Director | Grant or award | Common Stock | 8,067 | - | - | |
| Richard C. Pfenniger Jr. - Director | Grant or award | Common Stock | 8,067 | - | - | |
| Phillip Md Et Al Frost - Director | Grant or award | Common Stock | 27,100 | - | - | |
| Sam Lee - Officer | Grant or award | Common Stock | 40,000 | - | - | |
| Roger D. Kornberg - Director | Grant or award | Common Stock | 28,109 | - | - | |
| Anthony J. Japour - Director | Grant or award | Common Stock | 14,924 | - | - | |
| James Joseph Martin - Officer | Grant or award | Common Stock | 40,000 | - | - | |
| Steven D. Rubin - Director | Grant or award | Common Stock | 18,957 | - | - |
Cocrystal Pharma, Inc. (COCP) had 3 insider filings in the last 90 days, with the most recent on 2026-08-06. The full record for COCP runs to 30 Form 4 filings, the earliest from 2024-10-11. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
2 insider purchases of COCP were filed in the last 90 days, totaling $80K.
No insider sales of COCP were filed in the last 90 days.
This page tracks COCP Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add COCP to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
